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Carcinosarcoma of the uterine cervix is less common than its counterpart in the uterine corpus. On the other hand,
mesonephric adenocarcinoma is also a rare neoplasm in the uterine cervix, and it has been reported that
mesonephric adenocarcinomas are often accompanied by sarcomatous components. We present a case of
mesonephric adenocarcinoma with a sarcomatous component which arose in a 63-year-old postmenopausal
woman. The hysterectomy specimen grossly showed an exophytic mass measuring 1.8 cm in the uterine cervix.
Histologically, diffuse mesonephric hyperplasia and adenocarcinoma with malignant spindle cell proliferation was
recognized, and therefore the tumor was diagnosed as “mesonephric adenocarcinoma with a sarcomatous
component.” The review of the literature of cervical carcinosarcoma and cervical mesonephric adenocarcinoma
revealed that 16% of cervical carcinosarcoma is of mesonephric duct origin, and that mesonephric adenocarcinoma
seems to be more likely to have sarcomatous change. We think the presence of a sarcomatous component in the
cervical biopsy specimen could be helpful in the diagnosis of mesonephric duct origin.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1243996503911062
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Carcinosarcoma is the neoplasm composed of malignant
epithelial and mesenchymal components, and a mesenchy-
mal component of carcinosarcoma is recently considered
as a metaplastic change of carcinoma. Carcinosarcoma
arises less frequently in the uterine cervix and the vulva,
than in the uterine corpus [1,2]. Although not much atten-
tion has been paid to it, cervical carcinosarcoma can be
characterized by having two different origins: the Müllerian
ducts and the mesonephric duct remnants [3-7]. Meso-
nephric adenocarcinoma arises from mesonephric duct
remnants. Unlike the usual endocervical-type adenocarcin-
oma, it is known that mesonephric adenocarcinoma is not* Correspondence: m_yasuda@saitama-med.ac.jp
1Departments of Pathology, Saitama Medical University International Medical
Center, 1397-1 Yamane, Hidaka, Saitama 350-1128, Japan
Full list of author information is available at the end of the article
© 2013 Meguro et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrelated to human papillomavirus (HPV) infection [5,8-10].
We present a case of mesonephric adenocarcinoma with a
sarcomatous component arising from mesonephric hyper-
plasia of the uterine cervix, and comprehensively review
the literature of the cervical carcinosarcoma arising from
Müllerian ducts and mesonephric ducts.
Case presentation
A 63-year-old, Japanese postmenopausal woman with
abnormal vaginal bleeding consulted our hospital. MR
imaging showed an enhanced uterine cervical mass
measuring 2.0 cm in diameter. There was no evidence
of lymphadenopathy or metastasis. The cervical biopsy
specimen showed diffuse malignant spindle cell prolif-
eration with myxoid stroma. The tumor cells were fo-
cally arranged in small nests or glands, resulting in a
diagnosis of undifferentiated carcinoma. The patient
underwent radical hysterectomy, bilateral salpingo-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 The microscopic view of mesonephric hyperplasia. In
mesonephric hyperplasia, the cytological atypia was bland and
mitotic figures were rarely seen.
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adjuvant chemotherapy. Seven months after the oper-
ation, the patient was treated by chemoradiative therapy
because of local recurrence, and the recurrent tumor
disappeared after three months of the therapy.
The hysterectomy specimen grossly showed an exophytic
mass in the left lateral wall of the cervix, measuring 1.8 cm
(Figure 1). Microscopically, mesonephric hyperplasia of the
diffuse type (Figure 2) extended to the entire circumfer-
ences of the cervix, and a small number of mesonephric tu-
bules were found in the vagina and myometrium. In the
adjacent area of mesonephric hyperplasia, adenocarcinoma
composed of small irregular glands was observed. Com-
pared to hyperplasia, these irregular glands had severe cyto-
logical atypia (Figure 3). Papillary pattern and ductal pattern
were also present (Figure 4). Furthermore, a sarcomatous
component composed of polygonal and spindle-shaped cells
was recognized (Figure 5), and there was a transition from
the adenocarcinomatous component to the sarcomatous
component (Figure 6). No heterologous component was
noted. The sarcomatous component was interpreted as un-
differentiated carcinoma as in the previous biopsy specimen.
The results of the immunohistochemical study are shown in
Table 1. Based on these findings, the diagnosis of meso-
nephric adenocarcinoma with a sarcomatous component
arising in mesonephric hyperplasia was finally confirmed,
being staged at pT2a because of minimal invasion of the
adenocarcinoma into the vaginal wall.Figure 1 Loupe view of the uterine cervical tumor. The tumor
showed exophytic polypoid growth. The area of hyperplasia
(enclosed by the dotted line) covered about 20% of the lesion, and
the adenocarcinoma area (solid line) covered about 40%. The
carcinosarcoma component (unenclosed area of the polypoid lesion)
accounted for about 40%.Discussion
The mesonephric ducts run parallel to the Müllerian ducts
in the fetus, and regress as female development progresses
[11]. Mesonephric remnants are detected by chance in the
lateral wall of the vagina and uterus, the broad ligament,
the mesosalpinx, or the ovarian hilus, and occur at a fre-
quency of about 20% in the adult uterine cervix [12]. The
remnants sometimes become hyperplastic, and rarely me-
sonephric adenocarcinoma can develop with the back-
ground of remnants or hyperplasia.
The present case was characterized by the presence of a
sarcomatous component. In the biopsy specimen, because
only a spindled cell component was obtained, the tumor
was initially diagnosed as “undifferentiated carcinoma.” In
the previous literature, differential diagnoses of mesoneph-
ric adenocarcinoma included clear cell adenocarcinoma,Figure 3 Mesonephric adenocarcinoma in the adjacent area of
mesonephric hyperplasia. The adenocarcinoma cells were
arranged as small irregular glands.
Figure 4 Mesonephric adenocarcinoma with papillary and
ductal structures. Papillary and ductal patterns were also observed
in a part of the adenocarcinoma component.
Figure 6 A transition between the carcinomatous component
and the sarcomatous component.
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usual endocervical-type adenocarcinoma, and minimal de-
viation adenocarcinoma [5,13]. However, it was not until
recently that attention has been paid to the presence of a
sarcomatous component as a helpful tool in the differential
diagnosis of mesonephric adenocarcinoma.
Including the present case, 42 cases with mesonephric
adenocarcinoma of the uterine cervix have been reported
in the English literature. Ten out of the 42 cases (24%) had
a sarcomatous component (Table 2) [3-7]. Regarding these
10 cases, the mean occurrence age was 54 years; tumor size
ranged from 1.8 to 8.0 cm (mean 4.5) in the largest diam-
eter; and 4 of the tumors were grossly exophytic or polyp-
oid lesions [3,4,7]. The sarcomatous components were as
follows: spindle cell sarcoma in 6 cases [3-5]; osteosarcoma
in 2 cases [3,6,7]; chondrosarcoma in 1 case [4]; rhabdo-
myosarcoma in 1 case [4].Figure 5 The sarcomatous component. The sarcomatous
component was composed of spindle cell proliferation.On the other hand, including this case, 61 cases of cer-
vical carcinosarcoma have been reported in the English lit-
erature. Of these, 10 cases (16%) were of mesonephric duct
origin, and 51 cases (85%) were of Müllerian duct origin,
traditionally designated as malignant Müllerian mixed
tumor (MMMT). Regarding the epithelial component of
MMMT, adenocarcinoma and squamous cell carcinoma
were recognized with approximately the same frequency.
Basaloid carcinoma, adenoid basal carcinoma, and adenoid
cystic carcinoma were also observed in a few cases. Carci-
nosarcoma is an extremely rare tumor of the uterine cervix.
However, from the point view of mesonephric duct origin,
one-quarter of them have a sarcomatous component, and
they account for 16% of cervical carcinosarcoma. These
values may represent an overestimate since these are more
likely than the Müllerian variants to be reported in the lit-
erature. Even so, interestingly, it seems that mesonephric
adenocarcinoma is more likely to have sarcomatous change
than the usual uterine cervical carcinoma arising from
Müllerian ducts.
In the present case, the cervical tumor was initially diag-
nosed as “undifferentiated carcinoma” in the biopsy. Me-
sonephric adenocarcinomas are usually difficult to make a
correct diagnosis by small specimen of biopsy because of
their common occurrence site of the deep and lateral wall
of the uterine cervix. In addition, mesonephric adenocar-
cinomas are known immunohistochemically to express
CD10, calretinin, and androgen receptor [4,6,13,14], but
these immunohistochemical profiles have not been evalu-
ated enough in the sarcomatous component. Considering
that 16% of cervical carcinosarcoma is of mesonephric
duct origin, if a sarcomatous component is recognized in
the biopsy specimen, it may be suspected of being of me-
sonephric duct origin.
As with cervical squamous cell carcinoma, the associ-
ation between cervical adenocarcinoma of the usual type
Table 1 Antibodies used for immunohistochemical staining and its results
Antigen Antibodies Results
Clone Source Dilution Biopsy Hysterectomy
Adenoca. Sarscomatous component
AE1/AE3 AE1/AE3 Dako, Glostrup, Denmark 1: 50 + +++ -
CAM5.2 CAM5.2 BD Biosciences, California, USA 1: 2 ND* +++ -
vimentin V9 Dako 1: 100 +++ - +++
ER SP1 Roche Diagnostics, Basel, Switzerland 1: 1 - - -
PgR 1E2 Roche Diagnostics 1: 1 - - -
AR AR441 Dako 1: 50 ND* - -
CD10 56C6 Leica Microsystems, Newcastle, UK 1: 40 - ++ ++
calretinin 5A5 Leica Microsystems 1: 100 - + -
ND*, not done.
Immunopositivity was semi-quantitatively assessed as follows: 3+, more than 10% of the tumor cells positive; 2+, 1-10% of the tumor cells positive; 1+, less than
1% tumor cells positive; no tumor cell staining was considered negative.
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sonephric adenocarcinoma is not related to HPV infection
[5,8-10]. Although an HPV test was not performed in the
present case, the tumor is predicted to be HPV-negative.
Looking at Table 2, 2 cases (22%) died [3,4,6]; 2 cases
(22%) were alive with metastatic or local recurrent tumor
[3,4]; and 5 cases (56%) were free of disease [3,4,6]. In con-
trast, in the cases of mesonephric adenocarcinoma without
a sarcomatous component, 20% of cases died of the disease
[6,18-20]. It seems that there is no significant difference in
the prognosis between mesonephric adenocarcinoma with
and without a sarcomatous component, although it has
been previously reported that mesonephric adenocarcin-
oma with a sarcomatous component showed aggressive be-








1 Present case 63 1.8 Mesonephric adenoca. with sp
component
2 3 37 ND Mesonephric adenoca. with sp
component
3 3 40 ND Mesonephric adenoca. with sp
component
4 3 73 ND Mesonephric adenoca. with sp
component
5 4 54 6 Malignant mixed mesonephric
6 5 ND ND Mesonephric adenoca. With sp
component
7 3, 6 39 ND Mesonephric adenoca. with sp
component
8 7 65 3 Osteosarcoma associated with
rests
9 4 54 3.5 Malignant mixed mesonephric
10 4 62 8 Malignant mixed mesonephric
ND, not described; adenoca., adenocarcinoma; NED, no evidence of disease; AWD, aConclusion
We presented a case of mesonephric adenocarcinoma
with a sarcomatous component arising from mesonephric
hyperplasia of the uterine cervix. It seems that mesoneph-
ric adenocarcinoma is more likely to have sarcomatous
change. Mesonephric adenocarcinomas are difficult to
make a correct diagnosis by small biopsy specimens; how-
ever, the presence of a sarcomatous component could be
helpful in the diagnosis of mesonephric duct origin. Re-
garding the relation between the sarcomatous component
and prognosis, further studies are needed.
Consent
Written informed consent was obtained from the patient





indle cell No IIA NED 10 mo
indle cell No IB AWD 11 yr
indle cell No IB NED 2.3 yr
indle cell No IB NED 3 yr
tumor No IIA DOD 7 mo
indle cell No ND ND
indle cell Osteosarcoma IB DOD 6.2 yr
mesonephric Osteosarcoma IB NED 1 yr
11mo
tumor Chondrosarcoma IB NED 1 yr
1mo
tumor Rhabdomyosarcoma IVB AWD 3 yr
3mo
live with disease; DOD, dead of disease.
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